skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

Cortot, Alexis B ; Kherrouche, Zoulika ; Descarpentries, Clotilde ; Wislez, Marie ; Baldacci, Simon ; Furlan, Alessandro ; Tulasne, David

JNCI : Journal of the National Cancer Institute, 2017-05, Vol.109 (5) [Periódico revisado por pares]

United States: Oxford University Press (OUP)

Texto completo disponível

Citações Citado por
2
Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity
Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity

Yokoyama, Yuhki ; Matsumoto, Ayaka ; Hieda, Miki ; Shinchi, Yoshimi ; Ogihara, Eri ; Hamada, Mai ; Nishioka, Yu ; Kimura, Hiroshi ; Yoshidome, Katsuhide ; Tsujimoto, Masahiko ; Matsuura, Nariaki

Breast cancer research : BCR, 2014-06, Vol.16 (3), p.R66-R66, Article R66 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita

Kirschner, Martin ; Maurer, Angela ; Wlodarski, Marcin W ; Ventura Ferreira, Monica S ; Bouillon, Anne-Sophie ; Halfmeyer, Insa ; Blau, Wolfgang ; Kreuter, Michael ; Rosewich, Martin ; Corbacioglu, Selim ; Beck, Joachim ; Schwarz, Michaela ; Bittenbring, Jörg ; Radsak, Markus P ; Wilk, Christian Matthias ; Koschmieder, Steffen ; Begemann, Matthias ; Kurth, Ingo ; Schemionek, Mirle ; Brümmendorf, Tim H ; Beier, Fabian

Leukemia, 2018-08, Vol.32 (8), p.1762-1767 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
Material Type:
Artigo 		Adicionar ao Meu Espaço

Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments

Solomon, Benjamin ; Young, Richard J. ; Rischin, Danny

Seminars in cancer biology, 2018-10, Vol.52 (Pt 2), p.228-240 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

Jardim, Denis L. ; Goodman, Aaron ; de Melo Gagliato, Debora ; Kurzrock, Razelle

Cancer cell, 2021-02, Vol.39 (2), p.154-173 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Despierre, Evelyn ; Vergote, Ignace ; Anderson, Ryan ; Coens, Corneel ; Katsaros, Dionyssios ; Hirsch, Fred R. ; Boeckx, Bram ; Varella-Garcia, Marileila ; Ferrero, Annamaria ; Ray-Coquard, Isabelle ; Berns, Els M. J. J. ; Casado, Antonio ; Lambrechts, Diether ; Jimeno, Antonio

Targeted oncology, 2015-12, Vol.10 (4), p.583-596 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
7
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond

Keller, Laura ; Belloum, Yassine ; Wikman, Harriet ; Pantel, Klaus

British journal of cancer, 2021-01, Vol.124 (2), p.345-358 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
CircRNAs and cancer: Biomarkers and master regulators
CircRNAs and cancer: Biomarkers and master regulators
Material Type:
Artigo 		Adicionar ao Meu Espaço

CircRNAs and cancer: Biomarkers and master regulators

Arnaiz, Esther ; Sole, Carla ; Manterola, Lorea ; Iparraguirre, Leire ; Otaegui, David ; Lawrie, Charles H.

Seminars in cancer biology, 2019-10, Vol.58, p.90-99 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Marabelle, Aurélien ; Fakih, Marwan ; Lopez, Juanita ; Shah, Manisha ; Shapira-Frommer, Ronnie ; Nakagawa, Kazuhiko ; Chung, Hyun Cheol ; Kindler, Hedy L ; Lopez-Martin, Jose A ; Miller, Wilson H ; Italiano, Antoine ; Kao, Steven ; Piha-Paul, Sarina A ; Delord, Jean-Pierre ; McWilliams, Robert R ; Fabrizio, David A ; Aurora-Garg, Deepti ; Xu, Lei ; Jin, Fan ; Norwood, Kevin ; Bang, Yung-Jue

The lancet oncology, 2020-10, Vol.21 (10), p.1353-1365 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Mateo, J. ; Chakravarty, D. ; Dienstmann, R. ; Jezdic, S. ; Gonzalez-Perez, A. ; Lopez-Bigas, N. ; Ng, C.K.Y. ; Bedard, P.L. ; Tortora, G. ; Douillard, J.-Y. ; Van Allen, E.M. ; Schultz, N. ; Swanton, C. ; André, F. ; Pusztai, L.

Annals of oncology, 2018-09, Vol.29 (9), p.1895-1902 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (36.479)
  2. Revistas revisadas por pares (33.321)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (37.646)
  2. Book Chapters  (83)
  3. Livros  (39)
  4. Newsletter Articles  (12)
  5. magazinearticle  (2)
  6. Web Resources  (1)
  7. Dissertações  (1)
  8. Mais opções open sub menu

Assunto 

  1. Science & Technology  (37.393)
  2. Life Sciences & Biomedicine  (36.606)
  3. Humans  (34.972)
  4. Female  (21.149)
  5. Biomarkers, Tumor - Genetics  (19.212)
  6. Prognosis  (16.567)
  7. Male  (15.484)
  8. Middle Aged  (15.100)
  9. Tumors  (13.998)
  10. Aged  (12.394)
  11. Biomarkers  (10.522)
  12. Adult  (10.480)
  13. Gene Expression Regulation, Neoplastic  (8.998)
  14. Gene Expression  (8.977)
  15. Biomarkers, Tumor - Metabolism  (8.936)
  16. Cancer Research  (8.286)
  17. Cancer  (7.859)
  18. Medical Prognosis  (6.514)
  19. Mutation  (6.465)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1990  (57)
  2. 1990Até1997  (660)
  3. 1998Até2005  (2.736)
  4. 2006Até2014  (11.682)
  5. Após 2014  (22.674)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (37.745)
  2. Japonês  (7.776)
  3. Francês  (46)
  4. Norueguês  (25)
  5. Russo  (13)
  6. Alemão  (7)
  7. Chinês  (7)
  8. Turco  (2)
  9. Português  (2)
  10. Italiano  (1)
  11. Espanhol  (1)
  12. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.